Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and/or Paraortic Recurrences of Gynecologic Malignancies.

Ling DC, Vargo JA, Burton SA, Heron DE, Beriwal S.

Pract Radiat Oncol. 2019 Nov;9(6):418-425. doi: 10.1016/j.prro.2019.05.012. Epub 2019 May 28.

PMID:
31150869
2.

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins.

Bernard ME, Sutera PA, Iarrobino NA, Quan K, Burton SA, Bahary N, Hogg M, Zureikat A, Heron DE.

Adv Radiat Oncol. 2018 Nov 29;4(2):294-301. doi: 10.1016/j.adro.2018.11.007. eCollection 2019 Apr-Jun.

3.

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases.

Sutera P, Kalash R, Clump DA, D'Ambrosio D, Mihai A, Burton SA, Heron DE.

Adv Radiat Oncol. 2018 Sep 14;4(1):57-62. doi: 10.1016/j.adro.2018.09.001. eCollection 2019 Jan-Mar.

4.

Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.

Niu L, Chu LY, Burton SA, Hansen KJ, Panyam J.

J Control Release. 2019 Jan 28;294:268-278. doi: 10.1016/j.jconrel.2018.12.026. Epub 2018 Dec 17.

PMID:
30572036
5.

Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.

Sutera P, Clump DA, Kalash R, D'Ambrosio D, Mihai A, Wang H, Petro DP, Burton SA, Heron DE.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):116-122. doi: 10.1016/j.ijrobp.2018.08.027. Epub 2018 Aug 25.

PMID:
30149056
6.

Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field.

Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE.

Pract Radiat Oncol. 2018 May - Jun;8(3):e117-e123. doi: 10.1016/j.prro.2017.11.011. Epub 2017 Dec 8.

PMID:
29724402
7.

Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.

Ling DC, Flickinger JC, Burton SA, Heron DE, Quinn AE, Bejjani GK, Engh JA, Gerszten PC, Amankulor NM, Vargo JA.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):602-609. doi: 10.1016/j.ijrobp.2018.02.035. Epub 2018 Mar 6.

PMID:
29678526
8.

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease.

Dohopolski MJ, Horne Z, Clump D, Burton SA, Heron DE.

Cureus. 2018 Feb 7;10(2):e2167. doi: 10.7759/cureus.2167.

9.

Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma.

Quan K, Sutera P, Xu K, Bernard ME, Burton SA, Wegner RE, Zeh H, Bahary N, Stoller R, Heron DE.

Pract Radiat Oncol. 2018 Mar - Apr;8(2):95-106. doi: 10.1016/j.prro.2017.10.001. Epub 2017 Oct 7.

PMID:
29291966
10.

Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.

Horne ZD, Richman AH, Dohopolski MJ, Clump DA, Burton SA, Heron DE.

Lung Cancer. 2018 Jan;115:1-4. doi: 10.1016/j.lungcan.2017.10.014. Epub 2017 Nov 10.

PMID:
29290248
11.

Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy.

Sutera PA, Bernard ME, Gill BS, Quan K, Engh JA, Burton SA, Heron DE.

Future Oncol. 2017 Dec;13(29):2681-2690. doi: 10.2217/fon-2017-0226. Epub 2017 Dec 4.

PMID:
29198146
12.

One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review.

Sutera PA, Bernard ME, Gill BS, Harper KK, Quan K, Bahary N, Burton SA, Zeh H, Heron DE.

Front Oncol. 2017 Nov 14;7:272. doi: 10.3389/fonc.2017.00272. eCollection 2017.

13.

Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and Counseling.

Gogineni E, Vargo JA, Glaser SM, Flickinger JC, Burton SA, Engh JA, Amankulor NM, Beriwal S, Quinn AE, Ozhasoglu C, Heron DE.

Neurosurgery. 2018 Aug 1;83(2):203-209. doi: 10.1093/neuros/nyx376.

PMID:
28945873
14.

A margin distance analysis of the impact of adjuvant chemoradiation on survival after pancreatoduodenectomy for pancreatic adenocarcinoma.

Ocuin LM, Miller-Ocuin JL, Zenati MS, Vargo JA, Singhi AD, Burton SA, Bahary N, Hogg ME, Zeh HJ 3rd, Zureikat AH.

J Gastrointest Oncol. 2017 Aug;8(4):696-704. doi: 10.21037/jgo.2017.04.02.

15.

Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.

Holt DE, Bernard ME, Quan K, Clump DA, Engh JA, Burton SA, Heron DE.

J Cancer Res Ther. 2016 Oct-Dec;12(4):1243-1248. doi: 10.4103/0973-1482.199537.

16.

Preliminary evaluation of a gel tube agglutination major cross-match method in dogs.

Villarnovo D, Burton SA, Horney BS, MacKenzie AL, Vanderstichel R.

Vet Clin Pathol. 2016 Sep;45(3):411-6. doi: 10.1111/vcp.12374. Epub 2016 Jul 5. Erratum in: Vet Clin Pathol. 2016 Dec;45(4):733.

PMID:
27378560
17.

Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.

Quan K, Xu KM, Zhang Y, Clump DA, Flickinger JC, Lalonde R, Burton SA, Heron DE.

Semin Radiat Oncol. 2016 Apr;26(2):112-9. doi: 10.1016/j.semradonc.2015.11.007. Epub 2015 Nov 27. Review.

PMID:
27000507
18.

Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery.

Quan K, Xu KM, Lalonde R, Horne ZD, Bernard ME, McCoy C, Clump DA, Burton SA, Heron DE.

Front Oncol. 2015 Oct 6;5:213. doi: 10.3389/fonc.2015.00213. eCollection 2015.

19.

Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy.

Gill BS, Clump DA, Burton SA, Christie NA, Schuchert MJ, Heron DE.

Front Oncol. 2015 May 11;5:109. doi: 10.3389/fonc.2015.00109. eCollection 2015.

20.

Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis.

Holt DE, Gill BS, Clump DA, Leeman JE, Burton SA, Amankulor NM, Engh JA, Heron DE.

Front Oncol. 2015 Apr 8;5:84. doi: 10.3389/fonc.2015.00084. eCollection 2015.

21.

Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases: clinical outcomes, predictors of intracranial failure, and implications for optimal patient selection.

Ling DC, Vargo JA, Wegner RE, Flickinger JC, Burton SA, Engh J, Amankulor N, Quinn AE, Ozhasoglu C, Heron DE.

Neurosurgery. 2015 Feb;76(2):150-6; discussion 156-7; quiz 157. doi: 10.1227/NEU.0000000000000584.

PMID:
25549189
22.

Treatment of antibody-mediated rejection in renal transplant patients: a clinical practice survey.

Burton SA, Amir N, Asbury A, Lange A, Hardinger KL.

Clin Transplant. 2015 Feb;29(2):118-23. doi: 10.1111/ctr.12491. Epub 2015 Jan 4.

PMID:
25430052
23.

Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.

Davis KS, Vargo JA, Ferris RL, Burton SA, Ohr JP, Clump DA, Heron DE.

Oral Oncol. 2014 Nov;50(11):1104-8. doi: 10.1016/j.oraloncology.2014.08.004. Epub 2014 Aug 28.

24.

Association between excess body weight and urine protein concentration in healthy dogs.

Tefft KM, Shaw DH, Ihle SL, Burton SA, Pack L.

Vet Clin Pathol. 2014 Jun;43(2):255-60. doi: 10.1111/vcp.12139. Epub 2014 Apr 14.

PMID:
24731227
25.

Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.

Horne ZD, Clump DA, Shah S, Vargo JA, Burton SA, Christie NA, Schuchert MJ, Landreneau RJ, Luketich JD, Heron DE.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S3-4. doi: 10.1016/j.prro.2013.01.014. Epub 2013 Mar 25. No abstract available.

PMID:
24674539
26.

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.

Horne ZD, Clump DA, Vargo JA, Shah S, Beriwal S, Burton SA, Quinn AE, Schuchert MJ, Landreneau RJ, Christie NA, Luketich JD, Heron DE.

Radiat Oncol. 2014 Jan 30;9:41. doi: 10.1186/1748-717X-9-41.

27.

Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.

Leeman JE, Clump DA, Flickinger JC, Mintz AH, Burton SA, Heron DE.

Neuro Oncol. 2013 Dec;15(12):1732-8. doi: 10.1093/neuonc/not130.

28.

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.

Rajagopalan MS, Heron DE, Wegner RE, Zeh HJ, Bahary N, Krasinskas AM, Lembersky B, Brand R, Moser AJ, Quinn AE, Burton SA.

Radiat Oncol. 2013 Oct 31;8:254. doi: 10.1186/1748-717X-8-254.

29.

Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients.

Kim CH, Ling DC, Wegner RE, Flickinger JC, Heron DE, Zeh H, Moser AJ, Burton SA.

Radiat Oncol. 2013 Oct 16;8:240. doi: 10.1186/1748-717X-8-240.

30.

Fractionated stereotactic radiosurgery for large brain metastases.

Wegner RE, Leeman JE, Kabolizadeh P, Rwigema JC, Mintz AH, Burton SA, Heron DE.

Am J Clin Oncol. 2015 Apr;38(2):135-9. doi: 10.1097/COC.0b013e31828aadac.

PMID:
23563213
32.

Stereotactic radiosurgery for the treatment and palliation of base of skull metastases.

Clump DA, Leeman JE, Wegner RE, Burton SA, Mintz AH, Heron DE.

J Radiosurg SBRT. 2013;2(3):217-223.

33.

Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgery.

Olson AC, Wegner RE, Rwigema JC, Heron DE, Burton SA, Mintz AH.

J Cancer Res Ther. 2012 Jul-Sep;8(3):411-6. doi: 10.4103/0973-1482.103522.

34.

Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.

Bernard ME, Wegner RE, Reineman K, Heron DE, Kirkwood J, Burton SA, Mintz AH.

J Cancer Res Ther. 2012 Apr-Jun;8(2):215-21. doi: 10.4103/0973-1482.98973.

35.

Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.

Leeman JE, Clump DA, Wegner RE, Heron DE, Burton SA, Mintz AH.

Radiat Oncol. 2012 Jul 11;7:107. doi: 10.1186/1748-717X-7-107.

36.

Comparison of whole versus partial vertebral body stereotactic body radiation therapy for spinal metastases.

Patel VB, Wegner RE, Heron DE, Flickinger JC, Gerszten P, Burton SA.

Technol Cancer Res Treat. 2012 Apr;11(2):105-15.

PMID:
22335404
37.

Stereotactic radiosurgery to the resection cavity of brain metastases: a retrospective analysis and literature review.

Rwigema JC, Wegner RE, Mintz AH, Paravati AJ, Burton SA, Ozhasoglu C, Heron DE.

Stereotact Funct Neurosurg. 2011;89(6):329-37. doi: 10.1159/000330387. Epub 2011 Oct 14.

38.

Pathology in practice. Neutrophilic and histiocytic inflammation with intracellular bacteria (consistent with R equi).

O'Neil EJ, Horney BS, Gagnon RL, Burton SA.

J Am Vet Med Assoc. 2011 Jun 15;238(12):1561-3. doi: 10.2460/javma.238.12.1561. No abstract available.

PMID:
21671809
39.

Fractionated stereotactic radiosurgery for the treatment of meningiomas.

Bria C, Wegner RE, Clump DA, Vargo JA, Mintz AH, Heron DE, Burton SA.

J Cancer Res Ther. 2011 Jan-Mar;7(1):52-7. doi: 10.4103/0973-1482.80462.

40.

Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.

Torok JA, Wegner RE, Mintz AH, Heron DE, Burton SA.

Technol Cancer Res Treat. 2011 Jun;10(3):253-8.

PMID:
21517131
41.

Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.

Haley ML, Gerszten PC, Heron DE, Chang YF, Atteberry DS, Burton SA.

J Neurosurg Spine. 2011 Apr;14(4):537-42. doi: 10.3171/2010.12.SPINE10233. Epub 2011 Feb 11.

PMID:
21314284
42.

Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.

Torok J, Wegner RE, Burton SA, Heron DE.

Future Oncol. 2011 Jan;7(1):145-51. doi: 10.2217/fon.10.165. Review.

PMID:
21174545
43.

Linac-based stereotactic body radiation therapy for treatment of glomus jugulare tumors.

Wegner RE, Rodriguez KD, Heron DE, Hirsch BE, Ferris RL, Burton SA.

Radiother Oncol. 2010 Dec;97(3):395-8. doi: 10.1016/j.radonc.2010.09.004. Epub 2010 Oct 13.

PMID:
20950881
44.

The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.

Rwigema JC, Heron DE, Ferris RL, Andrade RS, Gibson MK, Yang Y, Ozhasoglu C, Argiris AE, Grandis JR, Burton SA.

Am J Clin Oncol. 2011 Aug;34(4):372-9. doi: 10.1097/COC.0b013e3181e84dc0.

45.

Combined endoscopic endonasal surgery and fractionated stereotactic radiosurgery (fSRS) for complex cranial base tumors-early clinical outcomes.

Paravati AJ, Heron DE, Gardner PA, Snyderman C, Ozhasoglu C, Quinn A, Burton SA, Seelman K, Mintz AH.

Technol Cancer Res Treat. 2010 Oct;9(5):489-98.

PMID:
20815420
46.

Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins.

Rwigema JC, Heron DE, Parikh SD, Zeh HJ 3rd, Moser JA, Bahary N, Ashby K, Burton SA.

J Gastrointest Cancer. 2012 Mar;43(1):70-6. doi: 10.1007/s12029-010-9203-7.

PMID:
20809393
47.

Cutaneous and tendon sheath mastocytomas with eosinophilic joint and tendon sheath effusions in a horse.

Uehlinger FD, Burton SA, Riley CB, Wichtel ME, Bourque AC.

J Vet Intern Med. 2010 Sep-Oct;24(5):1233-6. doi: 10.1111/j.1939-1676.2010.0570.x. Epub 2010 Aug 12. No abstract available.

48.

Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.

Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn AE, Ferris RL.

Am J Clin Oncol. 2011 Apr;34(2):165-72. doi: 10.1097/COC.0b013e3181dbb73e.

PMID:
20686406
49.

Rapid intradermal delivery of liquid formulations using a hollow microstructured array.

Burton SA, Ng CY, Simmers R, Moeckly C, Brandwein D, Gilbert T, Johnson N, Brown K, Alston T, Prochnow G, Siebenaler K, Hansen K.

Pharm Res. 2011 Jan;28(1):31-40. doi: 10.1007/s11095-010-0177-8. Epub 2010 Jun 26.

50.

Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas.

Rwigema JC, Parikh SD, Heron DE, Howell M, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA.

Am J Clin Oncol. 2011 Feb;34(1):63-9. doi: 10.1097/COC.0b013e3181d270b4.

PMID:
20308870

Supplemental Content

Loading ...
Support Center